Ongoing Studies – Currently Recruiting
Ongoing Studies – No Longer Recruiting
CHRONIC SPONTANEOUS URTICARIA
To demonstrate the efficacy of dupilumab in study participants with CSU who remain symptomatic despite the use of H1 antihistamine (Study A: omalizumab naïve; Study B: omalizumab intolerant or incomplete responders) (CUPID)
https://clinicaltrials.gov/ct2/show/NCT04180488
A Phase III Extension Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.(PEARL-E1)
https://clinicaltrials.gov/ct2/show/NCT03580356?term=NCT03580356&rank=1
HEREDITARY ANGIOEDEMA
A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (VANGUARD)
https://clinicaltrials.gov/ct2/show/NCT03712228?term=NCT03712228&rank=1
ASTHMA
This study will generate patient reported outcomes (PROs) associated with the use of benralizumab (Fasenra) as treatment for severe eosinophilic asthma. (POWER)
https://clinicaltrials.gov/ct2/show/NCT03833141
DUST MITE ALLERGY
A research study of how house dust mite tablets work compared to placebo in children aged between 5 and 11 years and who have allergy to house dust mites. (MT-12)
https://clinicaltrials.gov/ct2/show/NCT04145219
PEANUT ALLERGY
Long-term Safety Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)
https://clinicaltrials.gov/ct2/show/NCT03292484?term=NCT03292484&rank=1
Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children (PEOPLE)
https://clinicaltrials.gov/ct2/show/NCT03013517?term=NCT03013517&rank=1
Safety Study of Viaskin Peanut to Treat Peanut Allergy (REALISE)
https://clinicaltrials.gov/ct2/show/NCT02916446?term=NCT02916446&rank=1
MILK ALLERGY
Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow’s Milk Allergy (MILES)
https://clinicaltrials.gov/ct2/show/NCT02223182?term=NCT02223182&rank=1
GRASS POLLEN ALLERGY
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy (LIBERTY AID)
https://clinicaltrials.gov/ct2/show/NCT03558997?term=NCT03558997&rank=1
ATOPIC DERMATITIS/ECZEMA
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials (ECZTEND)
https://clinicaltrials.gov/ct2/show/NCT03562377?term=NCT03562377&rank=1
HEREDITARY ANGIOEDEMA
Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema
https://clinicaltrials.gov/ct2/show/NCT03240133?term=NCT03240133&rank=1
